Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

A plasma protein classifier for predicting amyloid burden for preclinical Alzheimer's disease.

Ashton NJ, Nevado-Holgado AJ, Barber IS, Lynham S, Gupta V, Chatterjee P, Goozee K, Hone E, Pedrini S, Blennow K, Schöll M, Zetterberg H, Ellis KA, Bush AI, Rowe CC, Villemagne VL, Ames D, Masters CL, Aarsland D, Powell J, Lovestone S, Martins R, Hye A.

Sci Adv. 2019 Feb 6;5(2):eaau7220. doi: 10.1126/sciadv.aau7220. eCollection 2019 Feb.

2.

Plasma Protein Biomarkers for the Prediction of CSF Amyloid and Tau and [18F]-Flutemetamol PET Scan Result.

Westwood S, Baird AL, Hye A, Ashton NJ, Nevado-Holgado AJ, Anand SN, Liu B, Newby D, Bazenet C, Kiddle SJ, Ward M, Newton B, Desai K, Tan Hehir C, Zanette M, Galimberti D, Parnetti L, Lleó A, Baker S, Narayan VA, van der Flier WM, Scheltens P, Teunissen CE, Visser PJ, Lovestone S.

Front Aging Neurosci. 2018 Dec 11;10:409. doi: 10.3389/fnagi.2018.00409. eCollection 2018.

3.

Cross-sectional and longitudinal analyses of outdoor air pollution exposure and cognitive function in UK Biobank.

Cullen B, Newby D, Lee D, Lyall DM, Nevado-Holgado AJ, Evans JJ, Pell JP, Lovestone S, Cavanagh J.

Sci Rep. 2018 Aug 14;8(1):12089. doi: 10.1038/s41598-018-30568-6.

4.

Red blood cell indices and anaemia as causative factors for cognitive function deficits and for Alzheimer's disease.

Winchester LM, Powell J, Lovestone S, Nevado-Holgado AJ.

Genome Med. 2018 Jun 28;10(1):51. doi: 10.1186/s13073-018-0556-z.

5.

NRF2 deficiency replicates transcriptomic changes in Alzheimer's patients and worsens APP and TAU pathology.

Rojo AI, Pajares M, Rada P, Nuñez A, Nevado-Holgado AJ, Killik R, Van Leuven F, Ribe E, Lovestone S, Yamamoto M, Cuadrado A.

Redox Biol. 2017 Oct;13:444-451. doi: 10.1016/j.redox.2017.07.006. Epub 2017 Jul 5.

6.

The influence of insulin resistance on cerebrospinal fluid and plasma biomarkers of Alzheimer's pathology.

Westwood S, Liu B, Baird AL, Anand S, Nevado-Holgado AJ, Newby D, Pikkarainen M, Hallikainen M, Kuusisto J, Streffer JR, Novak G, Blennow K, Andreasson U, Zetterberg H, Smith U, Laakso M, Soininen H, Lovestone S.

Alzheimers Res Ther. 2017 Apr 26;9(1):31. doi: 10.1186/s13195-017-0258-6. Review.

7.

Commonly prescribed drugs associate with cognitive function: a cross-sectional study in UK Biobank.

Nevado-Holgado AJ, Kim CH, Winchester L, Gallacher J, Lovestone S.

BMJ Open. 2016 Nov 30;6(11):e012177. doi: 10.1136/bmjopen-2016-012177.

8.
9.

Intact action segmentation in Parkinson's disease: Hypothesis testing using a novel computational approach.

Schiffer AM, Nevado-Holgado AJ, Johnen A, Schönberger AR, Fink GR, Schubotz RI.

Neuropsychologia. 2015 Nov;78:29-40. doi: 10.1016/j.neuropsychologia.2015.09.034. Epub 2015 Sep 30.

PMID:
26432343
10.

Oscillatory activity in the medial prefrontal cortex and nucleus accumbens correlates with impulsivity and reward outcome.

Donnelly NA, Holtzman T, Rich PD, Nevado-Holgado AJ, Fernando AB, Van Dijck G, Holzhammer T, Paul O, Ruther P, Paulsen O, Robbins TW, Dalley JW.

PLoS One. 2014 Oct 21;9(10):e111300. doi: 10.1371/journal.pone.0111300. eCollection 2014.

11.

Effective connectivity of the subthalamic nucleus-globus pallidus network during Parkinsonian oscillations.

Nevado-Holgado AJ, Mallet N, Magill PJ, Bogacz R.

J Physiol. 2014 Apr 1;592(7):1429-55. doi: 10.1113/jphysiol.2013.259721. Epub 2013 Dec 16.

12.

Characterising the dynamics of EEG waveforms as the path through parameter space of a neural mass model: application to epilepsy seizure evolution.

Nevado-Holgado AJ, Marten F, Richardson MP, Terry JR.

Neuroimage. 2012 Feb 1;59(3):2374-92. doi: 10.1016/j.neuroimage.2011.08.111. Epub 2011 Sep 14.

PMID:
21945471

Supplemental Content

Loading ...
Support Center